The Dawning of Friends of Science in Medicine (FSM)

Every era gets the healthcare it deserves. Ours comes with astonishing breakthroughsgene therapies, targeted cancer drugs,
AI that can spot patterns humans missand also a never-ending parade of “ancient secrets doctors don’t want you to know”
served with a side of influencer lighting.

If you’ve ever watched a relative forward a video claiming that a “detox foot patch” can remove “heavy metals” through
“negative ions,” you already understand the core problem: science moves carefully; nonsense moves fast.
And once nonsense gets a lab coat (or worse, a university course code), it becomes harder to challenge without sounding
like the villain who hates joy.

That’s where Friends of Science in Medicine (FSM) comes inan unapologetically evidence-first group
that formed to defend science-based healthcare and push back against unsubstantiated therapies, magical thinking, and
health fraud. FSM is based in Australia, but the pressures that sparked itmisinformation, commercialization, and
“credibility laundering”are painfully global, including in the United States.

What FSM is (and what it isn’t)

Friends of Science in Medicine was launched in December 2011 with a simple, spicy premise:
healthcare education and practice should be grounded in credible scientific evidence.
FSM’s founders and early leaders included clinicians and academics who were frustrated by how easily unsupported
practices could be marketed, taught, and normalized under the warm umbrella of “complementary” care.

FSM’s stance isn’t “all non-mainstream ideas are bad.” It’s sharperand more reasonable:
claims should earn their legitimacy the same way any medical claim does. If something works, it’s medicine.
If it doesn’t, it shouldn’t get a free pass because it’s “natural,” “traditional,” or “what my cousin swears by.”

Small but important clarification: FSM is not related to similarly named advocacy groups in other domains. In modern
life, naming collisions happen. It’s like trying to find “Mercury” on the internet and getting a planet, a metal,
and a 1970s sedannone of which should be used to treat your migraines.

Why a “friends of science” movement was inevitable

FSM didn’t pop up because people suddenly became irrational in 2011. People have always wanted hope, and hope is a
powerful sales tool. FSM emerged because three forces collided:

• Information overload: When everyone can publish, confidence often beats competence.
• Institutional drift: Schools and clinics face pressure to offer what’s popular, not just what’s proven.
• Commercial incentives: A miracle cure is hard to regulate and easy to monetize.

In the U.S., those same forces show up in familiar ways: a booming supplement marketplace, health marketing that
sprints ahead of evidence, and a social media ecosystem where “before-and-after” photos are treated like clinical trials.

The U.S. angle: supplements, claims, and the “food-not-drug” loophole vibe

One reason science-based medicine needs loud friends is that not everything sold for health is evaluated like medicine.
In the United States, dietary supplements are regulated differently than drugs, and the FDA’s role is not the same as
pre-market drug approval. That doesn’t mean supplements are automatically harmfulbut it does mean consumers can face
confusing claims, variable quality, and occasional outright fraud.

Add the reality that some products marketed as supplements have been found to contain hidden drug ingredients, and you
start to see the problem: the line between “wellness” and “risk” can get thin fast.

Medical misinformation: a public health issue, not a quirky personality trait

The U.S. Surgeon General has described health misinformation as a serious threat that can harm health, sow mistrust,
and undermine public health efforts. When misinformation spreads faster than corrections, people don’t just get confused
they delay care, abandon effective treatments, and sometimes pursue dangerous alternatives.

FSM’s origin story is essentially a case study in what happens when misinformation and institutional credibility
start holding hands.

Science-based medicine, explained like you’re busy

Evidence-based medicine (EBM) is often summarized as combining the best available research evidence with
clinical expertise and patient values. In other words: science tells us what’s likely to work,
clinicians tailor it, and patients decide what matters most in their lives.

Good EBM is not a cold robot reading PDFs at you. It’s closer to a high-stakes group project where everyone brings a
different superpower:

• Research provides probabilities, not guarantees.
• Clinicians interpret evidence in the context of a real human sitting in front of them.
• Patients bring goals, risk tolerance, culture, budget, and lived reality.

The “how” matters: systematic reviews and updating the evidence

Single studies can misleadespecially small ones, poorly designed ones, or the kind that get shared because the headline
is exciting. That’s why systematic reviews exist: to evaluate bodies of evidence using transparent methods. In the U.S.,
evidence programs and systematic-review infrastructure (including work associated with AHRQ’s evidence activities) help
clinicians and policymakers make decisions based on the totality of data rather than the loudest outlier.

The point isn’t to worship research. The point is to reduce avoidable mistakesthe kind that happen when we
confuse “I heard” with “we know.”

FSM’s playbook: how credibility gets abused

From FSM’s early history, one theme keeps repeating: unsupported ideas often win not by evidence, but by
presentation. They borrow credibility the way a teenager borrows a parent’s credit cardfast, confident,
and hoping nobody checks the receipt.

1) The “university halo” effect

When a university offers a course, many people assume the content has been vetted with scientific rigor. FSM’s early
concerns included universities promoting or teaching non-evidence-based modalities in ways that could make them appear
medically legitimate. Once an idea gets academic framing, critics can be painted as “anti-education” rather than
“pro-evidence.”

In the U.S., you see similar dynamics whenever marketing says, “Clinically studied” without telling you the study was
tiny, unblinded, or conducted by the company selling the product. The problem isn’t curiosity. The problem is
credentialed persuasion without accountability.

2) The language trick: “complementary” vs “alternative”

Words do a lot of work in health. “Complementary” sounds like support. “Alternative” sounds like replacement.
That distinction matters because replacing effective treatment with ineffective treatment can raise risks dramatically.
A major U.S. study published in JAMA Oncology found an association between receiving “complementary medicine,”
refusal of conventional cancer treatment, and worse survival among patients with curable cancerssuggesting the danger
often comes from delayed or declined effective care, not necessarily the add-on practice itself.

To be clear: some supportive practices (like relaxation techniques, movement, and certain symptom-management strategies)
can be helpful when evidence supports them and when they don’t crowd out proven treatment. But “harmless” stops being
harmless when it becomes a substitute.

3) The marketing pipeline: from claim to cash, with minimal friction

In the U.S., the Federal Trade Commission (FTC) emphasizes that companies must have appropriate substantiation for
health-related advertising claims. That principleshow your workis basically FSM’s worldview in one sentence.

FSM’s broader message aligns with a simple consumer-protection idea: extraordinary health claims should require
extraordinary evidence, not extraordinary confidence.

What the U.S. can learn from FSM (without copying and pasting a constitution)

FSM is Australian, but its biggest contribution may be the template it provides for civic action around science-based care:
organize, communicate clearly, and push institutions to justify what they teach and endorse.

The U.S. already has adjacent movements that share the same DNA. One of the most recognizable is
Choosing Wisely, which aimed to spark conversations between clinicians and patients about unnecessary
tests and treatmentscare that isn’t supported by evidence, duplicates prior work, or risks harm without benefit.
Different target, same principle: medicine should be accountable to evidence and outcomes.

A “friends of science” approach in U.S. medicine could focus on practical wins:

• Stronger health-claim accountability: clearer standards for what “clinically proven” means in marketing.
• Better education: critical thinking and evidence literacy as core health skills, not electives.
• Institutional transparency: when hospitals and schools offer integrative services, show the evidence level and limits.
• Patient-centered communication: fewer lectures, more shared decision-making and values-based discussions.

A quick field guide to shaky medical claims

You don’t need a PhD to spot nonsense. You just need a small checklist and the courage to be the mildly annoying person
who asks follow-up questions. (History remembers those people fondly. Usually.)

Red flags that deserve a raised eyebrow

• “Cures everything.” If one thing treats migraines, arthritis, anxiety, gut issues, and your Wi-Fi reception, it’s probably marketing.
• “They don’t want you to know.” Science loves knowing things. That’s kind of the whole brand.
• Only testimonials, no data. Stories matter, but they’re not controlled experiments.
• Vague mechanisms. “Boosts your immune system” can mean nothing unless defined and measured.
• Pressure tactics. “Buy now before they ban it” is a sales strategy, not a clinical guideline.

Three questions worth asking (every time)

1. What’s the best evidence it works? Not “a study exists,” but the quality and consistency of evidence.
2. What are the risks and interactions? “Natural” can still be potentand can still collide with medications.
3. What happens if I do nothing or choose standard care? Opportunity cost is real in medicine.

Conclusion: Science needs friendsespecially in medicine

FSM’s story is ultimately about a timeless tension: people want relief now, while science earns confidence slowly.
The solution isn’t to mock hope. The solution is to protect hope from exploitation.

Science-based medicine is not anti-tradition, anti-holistic, or anti-human. It’s anti-self-deception and anti-fraud.
It asks that claims be testable, results be reproducible, and risks be stated plainly. In a world where health advice can
go viral in minutes, that kind of discipline isn’t just academicit’s lifesaving.

If you take one thing from the dawning of Friends of Science in Medicine, let it be this:
skepticism isn’t cynicism. It’s a form of care.

Experiences: What It Feels Like When Science Has to Compete With a Viral Video

The debates around science-based medicine can sound abstractpolicy, education, regulation, evidence hierarchies.
But in day-to-day healthcare, the “science vs. pseudoscience” clash often arrives in ordinary moments that feel
intensely personal. The following scenes are composite experiences drawn from common patterns clinicians,
patients, educators, and pharmacists frequently describenot one person’s story, but many people’s reality stitched together.

Scene 1: The exam room negotiation. A physician explains that an antibiotic won’t treat a viral illness.
The patient nods… and then mentions a TikTok “protocol” involving megadoses of supplements and a “parasite cleanse.”
The doctor doesn’t roll their eyes (even though their soul tries). Instead, they ask what the patient is most worried about.
That question opens the door: fear of missing work, fear of “it getting worse,” fear of being dismissed. The conversation
shifts from “You’re wrong” to “Let’s make a plan.” Science-based medicine wins not by dunking, but by listening, then
offering a clear path forward.

Scene 2: The pharmacy reality check. A pharmacist spots a potential interaction between a supplement and
a prescription medication. The patient is surprisedbecause the bottle looks harmless, like it belongs next to granola.
They admit they didn’t mention it to their clinician because “it’s just vitamins.” The pharmacist gently explains that
“dietary supplement” doesn’t equal “risk-free,” and that some products have inconsistent ingredient lists. Nobody panics.
The goal is simply to reduce preventable harm. It’s not dramatic. It’s not viral. It’s profoundly important.

Scene 3: The classroom credibility trap. A health professional student sits through a lecture where a
practitioner presents a therapy with confident diagrams, impressive jargon, and a few cherry-picked studies. The student
feels the internal conflict: “This is being taught here… so it must be legitimate, right?” Later, a mentor offers a
different lens: “Curiosity is good. But in medicine, we owe patients receipts.” That mentor doesn’t ban questions; they
teach evaluationstudy design, bias, plausibility, and the difference between ‘interesting’ and ‘true.’

Scene 4: The family group chat. A loved one shares a post claiming a “natural” alternative can replace
standard therapy for a serious condition. The pushback is immediatesomeone links an article, someone gets angry, someone
says, “Stop being negative.” This is where a “friends of science” mindset matters. The most effective reply often isn’t
a fact-bomb; it’s a compassionate question: “What are you hoping this will do?” and “Can we talk to your clinician
together?” People rarely abandon misinformation because they lost an argument. They abandon it when they feel safe enough
to change their mind.

Scene 5: The high-stakes fork in the road. A patient with a curable cancer hears about “complementary”
approaches. Some options help with symptoms and stress. Others promise to replace conventional treatment entirely.
The patient is exhausted, overwhelmed, and desperate for control. This is where science-based medicine becomes deeply human:
clinicians and supporters outline what evidence shows, what risks exist, and what delaying treatment could cost. The patient
is treated like a decision-maker, not a child. The message is not “Never do anything else,” but “Don’t trade proven survival
for a promise that can’t be verified.”

Scene 6: The public health communicator’s headache. A local health department posts careful guidance.
A flashy influencer posts a confident myth. Guess which one spreads faster. The communicator learns to translate evidence
into plain language, repeat it consistently, and partner with trusted community voices. They also learn that “being right”
isn’t enough; information has to be reachable, understandable, and relevant. Science needs friends
not because it’s fragile, but because attention is scarce and misinformation is loud.

Together, these experiences explain the real lesson behind FSM’s dawning: science-based medicine isn’t just a set of
rules. It’s a cultureone that protects patients by rewarding evidence, humility, and honesty. And like any culture,
it thrives when enough people decide to defend it in the places where it matters: clinics, classrooms, homes, and feeds.